Efficacy and safety of tacrolimus as long-term monotherapy for myasthenia gravis-Reference-Cited by-同舟云学术

Efficacy and safety of tacrolimus as long-term monotherapy for myasthenia gravis

Published:2021-06 Issue:6 Volume:31 Page:512-518
ISSN:0960-8966
Container-title:Neuromuscular Disorders
language:en
Short-container-title:Neuromuscular Disorders

Author:

Itani Kumi,Nakamura Masataka,Wate Reika,Kaneko Satoshi,Fujita Kengo,Iida Shin,Morise Satoshi,Murakami Aya,Kunieda Takenobu,Takenouchi Norihiro,Yakushiji Yusuke,Kusaka Hirofumi

Publisher

Elsevier BV

Subject

Genetics (clinical),Neurology (clinical),Neurology,Pediatrics, Perinatology and Child Health

Reference32 articles.

1. Myasthenia gravis;Gilhus;N Engl J Med,2016

2. Myasthenia gravis: subgroup classification and therapeutic strategies;Gilhus;Lancet Neurol,2015

3. International consensus guidance for management of Myasthenia gravis: executive summary;Sanders;Neurology,2016

4. Long-term administration of corticosteroids in myasthenia gravis;Mann;Neurology,1976

5. Myasthenia gravis: prolonged treatment with steroids;Sghirlanzoni;Neurology,1984

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Immunotherapy for Myasthenia Gravis;Advances in Clinical Medicine;2024

2. Long-term efficacy and safety of tacrolimus in young children with myasthenia gravis;Journal of Clinical Neuroscience;2023-10

3. T-cell receptor signaling modulated by the co-receptors: Potential targets for stroke treatment;Pharmacological Research;2023-06

4. Conventional and emerging treatments and controversies in myasthenia gravis;Expert Review of Neurotherapeutics;2023-05-03

5. Comparison between mono‐tacrolimus and mono‐glucocorticoid in the treatment of myasthenia gravis;Annals of Clinical and Translational Neurology;2023-02-20